Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:2352-2358

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zanzinger, J.
Right arrow Articles by Seller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zanzinger, J.
Right arrow Articles by Seller, H.

(Circulation. 1998;97:2352-2358.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Impaired Modulation of Sympathetic Excitability by Nitric Oxide After Long-term Administration of Organic Nitrates in Pigs

Johannes Zanzinger, PhD; Jürgen Czachurski, BEng; ; Horst Seller, MD

From the Institute of Physiology I, University of Heidelberg (Germany).

Correspondence to Dr J. Zanzinger, I. Physiologisches Institut, Im Neuenheimer Feld 326, D-69120 Heidelberg, FRG. E-mail zanzing{at}novsrv1.pio1.uni-heidelberg.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Endogenous nitric oxide (NO) reduces sympathetic vasoconstriction by attenuating neuronal excitability in the brain stem and inhibition of postganglionic neurotransmission. We studied whether this modulation of sympathetic circulatory control by NO may be altered during chronic administration of NO donor drugs in pigs.

Methods and Results—Nitrate tolerance was induced by oral administration of isosorbide dinitrate (ISDN, 4 mg/kg per day for 4 weeks) in eight pigs. Four of them were chronically instrumented for the measurement of mean arterial blood pressure and cardiac output in the conscious state. ISDN treatment caused hemodynamic tolerance to NO donors and significantly increased the hypotensive responses to pharmacologic ganglionic blockade in conscious pigs. In general anesthesia, ISDN-treated animals and age-matched controls (n=5) had similar baseline renal sympathetic nerve activity and in both groups neither inhibition of NO synthases (NOS) nor administration of NO donors to the brain stem by intracerebroventricular (ICV) infusions caused significant changes in baseline renal sympathetic nerve activity. However, whereas sympathoexcitatory responses to glutamate (0.5 mL, 0.1 mol/L, ICV) or electrical stimulation of somatic nerve afferents were significantly potentiated by central NOS inhibition and attenuated by NO donors in controls, these treatments no longer had significant effects in ISDN-treated pigs. Furthermore, reflex sympathetic activation in response to intravenous NO donor treatment was more pronounced in nitrate tolerant animals, which suggests loss of central sympathoinhibitory effects of NO. Subsequent histology on brain stem slices with NADPH-diaphorase as NOS marker revealed significant reduction of NOS density in ISDN-treated pigs.

Conclusions—Long-term administration of organic nitrates reduces the number of NO-producing neurons in the brain stem and causes loss of inhibitory effects of NO on sympathetic excitability. This component of tolerance to organic nitrates may be important in patients confronted frequently with sympathetic activation caused by mental and/or physical stressors.


Key Words: nitric oxide • brain • nervous system


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Endogenous NO regulates vascular tone by direct actions on smooth muscle1 2 and, in addition, to a significant extent by inhibition of sympathetic vasoconstrictor mechanisms.3 4 5 6 Organic nitrates that are known to act through the release of NO7 are widely used as vasodilator drugs. The efficacy of these drugs, however, can be severely impaired by the development of nitrate tolerance.8 9 Although it has been shown that NO release from organic nitrates is preserved during tolerance in vivo,10 reduced vasodilator effects of NO caused by enhanced endothelial superoxide production11 and endothelin-1 release12 may be causes of true vascular tolerance. In addition, neurohumoral activation and pseudotolerance associated with increased sympathetic activity have been proposed to contribute the phenomenon.13 Under physiologic conditions, NO inhibits sympathetic vasoconstrictor influences by both reducing the release of noradrenaline from postganglionic sympathetic fibers and by attenuation of neuronal sympathetic excitability within the medullary areas that regulate sympathetic outflow from the brain stem.3 14 15 Because impaired modulation of sympathetic functions by NO could contribute to nitrate tolerance, we studied whether long-term organic nitrate treatment affects basal and activated SNA in pigs and whether vasoconstrictor effects of SNA may be altered in nitrate tolerance in vivo. In addition, we studied the distribution of NOS within the lower brain stem in both control and nitrate-tolerant pigs by NADPH-diaphorase staining.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Long-term Experiments
Young farm pigs (n=4, 16 to 20 kg body wt) were sedated with ketamine (10 mg/kg IM) and anesthetized with pentobarbital (12 to 15 mg/kg IV). Anesthesia was maintained after intubation with isoflurane (1.0% to 1.5%) in the inspired air consisting of 2:1 N2O/O2. An aseptic left thoracotomy was performed through the fourth intercostal space under positive pressure respiration. The pulmonary artery was instrumented with an transient time ultrasonic flow probe (Triton, ART2) for measurement of cardiac output and with a chronic catheter for infusion of drugs. For measurement of arterial BP, another catheter was implanted in the ascending aorta. Catheters and wires were tunneled subcutaneously to the dorsal neck. The pigs received antibiotics (cephalosporin 1 mg/kg) and analgesia (metamizol 50 mg/kg) for 1 week after surgery and were allowed to recover from surgery for at least 7 days. During the recovery period, the pigs were made familiar with the laboratory and trained to rest quietly in a straw filled cage for experimental periods of {approx}1 hour. Measurements were subsequently made in conscious animals at least twice per week during continuous registration of all parameters. To monitor the development of nitrate tolerance, dose-response relations for the NO donor SNAP were performed by intravenous infusion after periods of registration of baseline hemodynamic parameters.

Throughout the study the pigs were fed with a standard diet (400 to 500 g/d of a cereal-based diet containing 12.6 MJ metabolizable energy/kg with 15.5% crude protein) and had free access to tap water. For induction of nitrate tolerance, pigs received 4 mg/kg per day ISDN with the diet. Two other groups of pigs were housed similarly but were not chronically instrumented. One group (n=4) received ISDN at the same dosage and the other group (n=5, control) was fed with a similar diet without drugs for the same duration. The mean weight gain throughout the study period was 428±39 g/d. All animals were studied in acute experiments (see below) subsequent to the chronic observations. The care of the pigs and the execution of the experimental protocol were supervised by an independent veterinarian in accordance with German laws and the animal welfare regulations of the University of Heidelberg.

Acute Experiments
Acute experiments were performed with similar general anesthesia as described for long-term experiments. For infusion of drugs and for measurement of blood pressure, catheters were placed into a femoral vein and artery (advanced in the abdominal aorta). Antibiotics (100 mg/kg ampicillin) were given to prevent possible influences of infections such as the induction of expression of inducible NOS by bacterial endotoxins. The pigs were paralyzed by 0.2 mg/kg per hour pancuronium bromide and artificially ventilated by a tracheal tube. End-tidal CO2 was kept at normal levels by adjustment of ventilatory depth and rate. Arterial blood gases were monitored with a blood gas analyzer (AVL 990, AVL List) and maintained in the normal range by administration of sodium bicarbonate solutions or adjustment of ventilation. Rectal temperature was maintained at 38.5°C by a thermostatically controlled infrared lamp. For measurements of CO in animals that were not instrumented long term, a biluminal (right atrium, pulmonary artery) 5F Swan-Ganz thermodilution catheter (Baxter) was inserted through a jugular vein and advanced through the right ventricle in the A pulmonalis under blood pressure control. In the other pigs CO was measured by the chronically implanted transient time flow probes (ART, Triton). The similarity of CO data has been checked in previous studies.15 For recording of RSNA, the left renal nerve was retroperitoneally exposed, placed on bipolar platinum electrodes, and kept in a mixture of petroleum jelly and paraffin oil. Neural signals were amplified (x20 000 to 50 000; Tektronix AM 502), filtered (2 to 3 kHz), and stored and analyzed with a CED 1401 interface connected to an 80486 PC computer. RSNA was full-wave rectified and then resistance-capacity integrated with a time constant between 7 to 10 ms. To activate somatosympathetic reflex responses, the left great sciatic nerve (N ischiadicus) was placed on bipolar platinum electrodes, embedded in petroleum jelly, and connected to an isolated stimulator (Digitimer). Stimulation was performed to produce reproducible submaximal excitatory effects on RSNA by using consecutive trains of 20-second length with 10 to 20 V, 30 Hz, and 0.5- to 1-ms pulse duration at intervals of 120 seconds.

Detection of NO Synthases Within the Brain Stem
Brain stems were removed from the skull and placed in 0.1 mol/L PBS (pH 7.4) containing 4% paraformaldehyde for at least 24 hours (at 4°C). After fixation, tissue from all animals was rinsed with pure PBS and placed in 15% sucrose containing PBS for cryoprotection. Cryotome sections were cut {approx}30 µm thick, and the free-floating sections were stained as follows. They were incubated in PBS containing 0.75 mg/mL of reduced nicotinamide adenine dinucleotide phosphate (NADPH, Boehringer, Mannheim) and 0.375 mg/mL nitro blue tetrazolium at 37°C for 3 hours. After incubation, the sections were rinsed in PBS, put on gelatin-coated glass slides, dried in air, dehydrated, and coverslipped in Permount. Mapping of the brain stem was done in analogy to Berman's atlas of the cat brain,16 and slices derived from similar rostrocaudal locations normalized to the overall size of the medulla were used for the study. The RVLM region was also functionally identified by microinjections of glutamate (500 nL, 0.5 mol/L) in three pigs in vivo, yielding maximal sympathoexcitatory responses on microinjections at the following distances relative to the obex: 4.5 to 5.0 mm lateral, 3.5 to 4.0 mm rostral, 5.0 to 6.0 mm deep (from the dorsal surface of the medulla). For statistical comparison of NOS density, NOS-positive cells on two slices ({approx}3.0 and 4.0 mm rostrally to the obex, respectively) were counted on a total area of 50 mm2 per animal including both the ventrolateral and the dorsal medullary region. As similarly observed in a previous study on different laboratory animal species,17 variation of NOS density between regions was small. Therefore, these data were pooled. NOS density is expressed in number of NOS-positive neurons/mm2 slice.

Drugs and Infusions
SNAP was from Alexis Chemicals. All other drugs were from Sigma. All drugs were dissolved in distilled water. For preparation of the final concentrations, the substances were further diluted in Ringer solution shortly before administration. For ICV-administrations, a catheter was inserted into the cerebroventricular space from the dorsal surface of the medulla at the level of the obex and advanced to the ventral surface of the medulla. The position of the catheter was functionally verified by instantaneous excitatory sympathetic responses to injections (0.3 mL) of glutamate, which are finally integrated within the brain stem by presympathetic neurones within the RVLM.15 18 Central NOS inhibition was carried out by short-term infusion (within 5 minutes, 1 mL/min ICV) of L-NNA (0.3 mmol/L). Effects of exogenous NO were tested by short-term ICV-infusion of SNAP (100 µmol/L) after NOS inhibition. As a test for central sympathetic excitability, 0.5 mL of 0.1 mol/L glutamate was injected (ICV) subsequent to the above pretreatments or sham control.

Data Analysis
HR was derived from the BP signal. TPR was calculated as (MAP-CVP)/CO, where central venous pressure (CVP) was assumed to be 2 mm Hg when no measured data were available (during CO measurements with flow probes). RSNA was resistance-capacity integrated and measured in arbitrary units (aU). CO and TPR measurements in chronically instrumented animals were normalized with respect to the increase in metabolic body mass (W0.75) during the study period. For presentation in summarizing figures, RSNA data were normalized and expressed in percentage of control values (%RSNA). All direct measurements were stored on a linear recorder (Gould) and on DAT tape for further computing. Responses to drugs were separately calculated as individual differences from pretreatment values. Responses to electrical stimulation were calculated as average peak values derived from three consecutive stimuli, respectively. All data were analyzed by ANOVA (for repeated measurements where appropriate). A comparison of the data obtained from chronically instrumented and noninstrumented ISDN-treated pigs (n=4 each) in the acute experiments revealed no significant differences, suggesting that the instrumentation procedure had no effect on the outcome of the study. Therefore these data were subsequently pooled for statistical evaluation. Comparison of means was carried out with Tukey's studentized range test. Differences of P<0.05 were considered to be significant. Values are reported as mean±SEM.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Assessment of Nitrate Tolerance in Conscious Pigs
Measurements of MAP, CO, and HR obtained from conscious pigs throughout the study period are shown in Figure 1Down. Chronic organic nitrate treatment (4 mg/kg per day) had only small hemodynamic effects. While significant increases in HR occurred during the first week of ISDN treatment, the other parameters were not significantly affected. However, as shown in Figure 2Down, significant impairment of the arterial vasodilatory effects of additional exogenous NO (SNAP, 30 to 300 µg/kg), as indicated by reduced changes in vascular resistance occurred already after the first week of ISDN treatment and was further enhanced until the fourth week of treatment. To get an estimate of the relevance of autonomic influences on blood pressure in awake animals, ganglionic neurotransmission was blocked by hexamethonium (0.5 mg/kg IV) in the four chronically instrumented pigs during control conditions and in the fourth week of ISDN treatment. Hexamethonium caused significantly less hypotension during control conditions (MAP fell from 92.1±3.1 to 80.4±4.5 mm Hg) than in the nitrate-tolerant state (99.2±2.9 versus 70.8±1.8 mm Hg).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Baseline hemodynamic parameters during long-term ISDN treatment (4 mg/kg per day) in conscious pigs (n=4). Course of MAP (in mm Hg), HR (in bpm), and normalized CO (L/min/kg W0.75) during the observation period of 5 weeks. *P<0.05 vs control values (week 0).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Development of nitrate tolerance during long-term ISDN treatment as indicated by reduced dilator effects of exogenous NO in conscious pigs (n=4). Effects of intravenous administration of the NO donor SNAP (30 to 300 µg/kg) on normalized TPR (in mm Hg/[L/min per kilogram W0.75]) are shown.

Changes in Sympathetic Functions Associated With Nitrate Tolerance
A comparison of baseline hemodynamics and RSNA between control and ISDN-treated pigs under general anesthesia in acute experiments is given in the TableDown. Figure 3Down shows original tracings of baseline hemodynamics and RSNA and responses to activation of somatosympathetic reflexes by electrical stimulation of the great sciatic nerve in a control and a nitrate-tolerant pig during similar general anesthesia. Baseline sympathetic activity was slightly higher in the tolerant pig, but comparable RSNA increases and hemodynamic responses to sciatic nerve stimulation could be evoked in both animals, which suggests maintained integrity of theses reflexes. A summary of the effects of reflex activation on MAP and RSNA for all animals and the effects of acute intracerebroventricular inhibition of NO synthesis or NO donor treatment in control and nitrate-tolerant animals is shown in Figure 4Down. In contrast to controls, ISDN-treated pigs no longer responded to the pharmacologic variation of NO availability within the brain stem. When, as shown in Figure 5Down, glutamate was injected intracerebroventricularly as a test for tonic excitation of medullary vasomotor neurons, the hypertensive effects were, albeit not significantly, greater in ISDN-treated pigs. The disappearence of sympathoinhibitory effects of NO after ISDN treatment was similarly observed.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Sympathetic Activity and Hemodynamics in Normal (n=5) and Nitrate-Tolerant Pigs (n=8) During Acute Experiments With General Anesthesia



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Representative tracings of effects of somatosympathetic reflex activation by electrical stimulation of the left greater sciatic nerve on renal sympathetic nerve activity (RSNA, {int}RN), blood pressure (BP), cardiac output (CO), and heart rate (HR) during control conditions in an anesthetized untreated and a chronically ISDN-treated pig (4 mg/kg per day), respectively.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 4. Disappearance of the sympathoinhibitory effects of central NO on somatosympathetic reflexes in nitrate tolerance. Summary of the effects of ICV treatment with sham control, L-NNA (0.3 mmol/L ICV), or SNAP (100 µmol/L ICV) on the responses of blood pressure ({Delta}MAP) and %RSNA to electrical stimulation of the left greater sciatic nerve (10 to 20 V, 1-ms pulse duration, 30 Hz for 20 seconds, every 2 minutes) in anesthetized control (n=5) and ISDN-treated pigs (n=8). Asterisks denote significant changes from control. *P<0.05, **P<0.01.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 5. Tolerance to inhibitory effects of NO on glutamate response in the ventrolateral medulla oblongata after long-term ISDN treatment. Effects of ICV treatment with sham (control), L-NNA (0.3 mmol/L ICV), or SNAP (100 µmol/L ICV) on the responses of blood pressure ({Delta}MAP) and %RSNA to ICV injections of glutamate (0.5 mL, 0.1 mol/L) in anesthetized control (n=5) and ISDN-treated pigs (n=8). Asterisks denote significant changes from control. *P<0.05, **P<0.01.

Effects of Central NOS Inhibition on Hemodynamic and Sympathetic Responses to Systemic Administration of NO Donors
To test whether nitrate tolerance may alter the impact of centrally acting NO on sympathetic and/or hemodynamic responses to systemically administered NO donors, SNAP (40 µg/kg) was given intravenously after NOS inhibition in the brain stem (ICV) in five control and four ISDN-treated pigs. The results are shown in Figure 6Down. Whereas SNAP caused significantly smaller decreases in blood pressure in nitrate-tolerant animals, the correspondent increases in sympathetic activity in response to baroreceptor unloading were even slightly greater than during control conditions.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6. Hypotensive and sympathoexcitatory effects of intravenous administration of NO donors in centrally NOS-blocked pigs. Effects of SNAP (40 µg/kg IV) on the responses of blood pressure ({Delta}MAP) and %RSNA in pigs (n=4 each) that were pretreated by ICV infusion of L-NNA (0.3 mmol/L ICV) are shown. Asterisks denote significant changes from control (*P<0.05).

NOS Density Within the Brain Stem
Figure 7ADown shows NADPH-positive structures within the brain stem at the level of the RVLM in a control and a nitrate-tolerant pig. A comparison of NOS density between control and nitrate-tolerant pigs is given in Figure 7BDown. Nitrate-tolerant pigs had significantly fewer NOS-positive neurons, which indicates that nitrate administration reduced NOS density by {approx}50% in these animals.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 7. Distribution of NOS within the lower brain stem in normal and nitrate-tolerant pigs. A, Representative photographs of NOS-positive neurons within the RVLM in a control and an ISDN-treated pig, respectively. B, Statistical comparison of NOS density in the lower brain stem (3 to 4 mm rostrally to the obex) expressed in numbers of NOS-positive neurons/mm2 slice. *P<0.05 vs control. C, Cross section of the lower brain stem (left side) of a pig at the level of the RVLM showing the position from which the magnified pictures in "A" were taken.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The major finding of this study is that long-term administration of exogenous NO in the form of organic nitrates may reduce endogenous NO synthesis within the brain stem and cause almost complete disappearance of the NO-mediated inhibition of sympathetic excitability observed in normal pigs. Such loss of sympathoinhibitory effects of both endogenous and exogenous NO after long-term nitrate administration may contribute to the clinical phenomenon of nitrate tolerance in patients receiving long-term nitrate therapy.

Impaired Inhibition of Sympathetic Excitability Versus Neurohumoral Activation
Our experiments suggest that the mechanisms underlying the observed changes in the modulation of sympathetic functions by NO during long-term nitrate treatment may be different from the so-called neurohumoral activation, which may be caused by stimulation of the renin-angiotensin system associated with blood volume expansion and increased circulating aldosterone levels in response to long-term treatment with organic nitrates.13 19 20 However, throughout the 4-week period of ISDN treatment in the pigs studied here, BP probably has always been higher than the threshold for significant activation of renin release. Moreover, increases in sympathetic activity that probably occurred in the animals are known to further increase this threshold.21 Furthermore, it has been recently shown in dogs22 and in patients23 24 that activation of the renin-angiotensin system may not be critically involved in nitrate tolerance. Nevertheless, the fact that heart rate was significantly increased during the first week of ISDN treatment could mean that some baroreflex-mediated increase in sympathetic activity may have initially contributed to the responses to ISDN.

Another factor contributing to nitrate tolerance, often called pseudotolerance,25 is the enhancement of sympathetic activity during long-term nitrate administration. Our results are largely in accordance with those of Stewart et al,25 who similarly observed in conscious dogs much greater decreases in MAP in response to ganglionic blockade by hexamethonium in nitrate-tolerant animals, suggesting that overall sympathetic activity may be markedly higher during nitrate tolerance. These authors also reported that during anesthesia, vasodilator effects of NO donors became considerably greater in tolerant dogs because of the reduced sympathetic activity under these conditions, which is in accordance with the present findings. However, the term pseudotolerance probably does not correctly describe the mechanisms underlying activation of sympathetic activity in nitrate tolerance. Together with our previous observations,15 the results of this study instead suggest that nitrates cause specific impairment (tolerance) of the modulatory effects of NO on sympathoexcitatory afferents to the vasomotor center in the brain stem, that is, the RVLM. A term such as "sympathetic tolerance" therefore would be more appropriate to describe this phenomenon. Sympathoexcitation by afferents to the RVLM is most important in the awake state when sympathetic activation can be caused by influences such as emotional stress, pain, exercise, or ventilatory dysfunctions.18 The relevance of an enhancement of the effects of these influences in nitrate tolerance are difficult to study and may become only fully apparent in normal living conditions. We used ICV-injections of glutamate and activation of somatosympathetic reflexes to study the role of these excitatory afferent influences in acute experiments during anesthesia.15

Relevance of the Central Effects of NO in the Vasodilator Effects of NO Donors In Vivo
We have recently characterized the mechanisms by which NO reduces central sympathetic excitability in normal pigs.15 In this and in a number of other studies,26 27 28 29 it has been shown that NO probably has no physiologically significant effects on the function of the sympathetic baroreceptor reflex. Therefore it is likely that the potentiation after long-term ISDN treatment of increases in sympathetic activity in response to intravenous administration of an NO donor (Figure 6Up) reflect the removal of centrally mediated sympathoinhibition by NO. In other words, in nontolerant animals, NO donors may have acted to a significant extent through central inhibition of sympathetic activity. In addition, the "sympathetic tolerance" may have prevented greater decreases in BP in response to the acute administration of the NO donor SNAP in the nitrate-tolerant animals. Tolerance to the effects of nitrates on sympathetic functions probably will be most important in vascular beds that are under strong control of sympathetic nerves. One can therefore expect that "sympathetic tolerance" may be primarily apparent in resistance vessels and less in large arterial vessel or veins. Previous observations suggest that this may be the case. In veins and large (epicardial) arterial vessels, the true vascular tolerance to nitrates appears to be more important, whereas tolerance on the level of resistance vessels may be more clearly dominated by sympathetic influences.8 9 25 However, despite the fact that nitrates are primarily given to reduce preload (effect on veins) and to dilate epicardial arteries, tolerance to the effects of NO on sympathetic functions may be nevertheless clinically relevant. Strong sympathoexcitation in patients with coronary artery disease may cause impaired myocardial perfusion and concomitantly increased myocardial oxygen consumption because of increased cardiac work (augmented TPR) and HR. Situations causing strong sympathetic activation may be more frequent in patients living at home than in patients in hospitals or in otherwise healthy experimental animals trained to rest quietly during laboratory measurements. Therefore it is possible that the relevance of "sympathetic tolerance" to organic nitrates may be higher in normal clinical situations than under study conditions.

Structural Changes in the Brain Stem Caused by Long-term ISDN Treatment
Within a period of 4 weeks, nitrate therapy reduced the number of NO-producing cells within the brain stem by {approx}50%. In addition, the activity of nNOS may also be reduced in nitrate tolerance through NO-induced inhibition of nNOS.30 Recent studies suggest that nNOS expression and activity within the brain can be relatively rapidly upregulated and downregulated.31 We used the relatively long period of treatment to allow the development of structural changes, to minimize the effects of initial short-term counterregulatory responses, and to achieve steady-state conditions. On the other hand, the long-term ISDN treatment protocol was chosen to simulate real long-term nitrate therapy that sometimes lasts several months or even years in patients. ISDN doses used in this study (4 mg/kg per day) would be in the upper range of therapeutic doses in patients. However, in the pigs studied here, these doses were still nonhypotensive. Furthermore, overall metabolism in growing young pigs is considerably higher than in mature humans. We therefore assume that the ISDN effects observed were within clinically relevant ranges.

Perspectives
We have shown that long-term administration of organic nitrates causes not only vascular tolerance but also a tolerance to the inhibitory effects of NO on sympathetic excitability. These functional alterations are associated with a reduction of NOS density within the brain stem. NO-induced downregulation of nNOS observed in the present study could also occur during inflammatory or infectious diseases associated with expression of inducible NOS when endogenous storage forms of NO such as S-nitrosothiols reach the brain through the bloodstream.32 33 Because sympathetic excitability of nitrate-tolerant pigs was considerably lower than that of normal pigs acutely treated (ICV) with NOS inhibitors, endogenous counterregulatory mechanisms may have partially replaced the functions of NO on central sympathoexcitatory neurons. It will be interesting to study these adaptations that prevent hypersensibility to sympathoexcitatory stimuli. Another important question to be studied is to what extent current concepts for the prevention of nitrate tolerance, for example, intermittent therapy,34 35 new NO donor compounds,36 or cotreatment with antioxidants,11 37 38 prevents or reduces the structural and functional changes in sympathetic functions caused by long-term nitrate therapy.


*    Selected Abbreviations and Acronyms
 
BP = blood pressure
CO = cardiac output
HR = heart rate
ICV = intracerebroventricular
ISDN = isosorbide dinitrate
L-NNA = nitro-L-arginine
MAP = mean arterial pressure
nNOS = neuronal NOS
NO = nitric oxide
NOS = NO synthase
PBS = phosphate-buffered saline
RSNA = renal sympathetic nerve activity
RVLM = rostral ventrolateral medulla
SNAP = S-nitroso-N-acetylpenicillamine
TPR = total peripheral resistance


*    Acknowledgments
 
This work was supported by the German Research Foundation (D.F.G.) grant Za 176/3–1. We would like to thank Manuela Höfer and Anita Kühner for skillful technical assistance and Gabi Froelich for help with the preparation of figures.

Received October 14, 1997; revision received December 29, 1997; accepted January 9, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Moncada S, Higgs A. Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012.[Free Full Text]
  2. Fleming I, Bauersachs J, Busse R. Paracrine functions of the coronary vascular endothelium. Mol Cell Biochem. 1996;157:137–145.[Medline] [Order article via Infotrieve]
  3. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073–1077.[Abstract/Free Full Text]
  4. Hirai T, Musch TI, Morgan DA, Kregel KC, Claassen DE, Pickar JG, Lewis SJ, Kenney MJ. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am J Physiol. 1995;269:R807–R813.[Abstract/Free Full Text]
  5. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res. 1993;72:511–516.[Abstract/Free Full Text]
  6. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension. 1994;23:971–975.[Abstract/Free Full Text]
  7. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol. 1994;24:555–566.[Abstract]
  8. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461–1467.[Abstract/Free Full Text]
  9. Bassenge E, Zanzinger J. Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function. Am J Cardiol. 1992;70:23B–29B.[Medline] [Order article via Infotrieve]
  10. Laursen JB, Mulsch A, Boesgaard S, Mordvintcev P, Trautner S, Gruhn N, Nielsenkudsk JE, Busse R, Aldershvile J. In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation. 1996;94:2241–2247.[Abstract/Free Full Text]
  11. Münzel T, Sayegh H, Freeman BA, Tarpey M, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest. 1995;95:187–194.
  12. Münzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A. 1995;92:5244–5248.[Abstract/Free Full Text]
  13. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336–2345.[Abstract/Free Full Text]
  14. Schwarz P, Diem R, Dun NJ, Förstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res. 1995;77:841–848.[Abstract/Free Full Text]
  15. Zanzinger J, Czachurski J, Seller H. Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs. Circ Res. 1997;80:565–571.[Abstract/Free Full Text]
  16. Berman AL. The Brain Stem of the Cat. Madison/Milwaukee, Wis: The University of Wisconsin Press; 1968.
  17. Zanzinger J, Seller H. Species differences in the distribution of nitric oxide synthase in brain stem regions that regulate sympathetic activity. Brain Res. 1997;764:265–268.[Medline] [Order article via Infotrieve]
  18. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 1994;74:323–364.[Free Full Text]
  19. Dupuis J, Lalonde G, Lemieux R, Rouleau J. Tolerance by intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990;16:923–931.[Abstract]
  20. Parker JO. Nitrate tolerance–problems both new and old. Can J Cardiol. 1996;12(suppl C):5C–8C.
  21. Kirchheim HR, Finke R, Hackenthal E, Löwe W, Persson P. Baroreflex sympathetic activation increases threshold pressure for the pressure-dependent renin release in conscious dogs. Pflugers Arch. 1985;405:127–135.[Medline] [Order article via Infotrieve]
  22. Münzel T, Bassenge E. Long-term angiotensin-converting enzyme inhibition with high dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation. 1996;93:2052–2058.[Abstract/Free Full Text]
  23. Münzel T, Heitzer T, Kurz S, Harrison DG, Luhman C, Pape L, Olschewski M, Just H. Dissociation of coronary vascular tolerance and neurohumoral adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J Am Coll Cardiol. 1996;27:297–303.[Abstract]
  24. Parker JD, Parker JO. Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. J Am Coll Cardiol. 1993;21:1445–1453.[Abstract]
  25. Stewart DJ, Elsner D, Sommer O, Holtz J, Bassenge E. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation. 1986;74:573–582.[Abstract/Free Full Text]
  26. Zanzinger J, Czachurski J, Seller H. Effects of nitric oxide on sympathetic baroreflex transmission in the nucleus tractus solitarii and caudal ventrolateral medulla in cats. Neurosci Lett. 1995;197:199–202.[Medline] [Order article via Infotrieve]
  27. Zanzinger J, Czachurski J, Seller H. Lack of nitric oxide sensitivity of carotid sinus baroreceptors activated by normal blood pressure stimuli in cats. Neurosci Lett. 1996;208:121–124.[Medline] [Order article via Infotrieve]
  28. Jimbo M, Suzuki H, Ichikawa M, Kumagai K, Nishizawa M, Saruta T. Role of nitric oxide in regulation of baroreceptor reflex. J Auton Nerv Syst. 1994;50:209–219.[Medline] [Order article via Infotrieve]
  29. Liu JL, Murakami H, Zucker IH. Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits. Am J Physiol. 1996;39:R1361–R1370.
  30. Griscavage JM, Fukuto JM, Komori Y, Ignarro LJ. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group: role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J Biol Chem. 1994;269:21644–21649.[Abstract/Free Full Text]
  31. Hökfelt T, Ceccatelli S, Gustafsson L, Hulting A-L, Verge V, Villar M, Xu X-J, Xu Z-Q, Wiesenfeld-Hallin Z, Zhang X. Plasticity of NO synthase expression in the nervous and endocrine systems. Neuropharmacology. 1994;33:1221–1227.[Medline] [Order article via Infotrieve]
  32. Scharfstein JS, Keaney JF Jr, Slivka A, Welch GN, Vita JA, Stamler JS, Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest. 1994;94:1432–1439.
  33. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-Nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221–226.[Medline] [Order article via Infotrieve]
  34. Abrams J. Interval therapy to avoid nitrate tolerance: paradise regained. Am J Cardiol. 1989;64:931–934.[Medline] [Order article via Infotrieve]
  35. Parker JO, Amies MH, Hawkinson RW, Heilman JM, Hougham AJ, Vollmer MC, Wilson RR. Intermittent transdermal nitroglycerin therapy in angina pectoris: clinically effective without tolerance or rebound: Minitran Efficacy Study Group. Circulation. 1995;91:1368–1374.[Abstract/Free Full Text]
  36. Zanzinger J, Feelisch M, Bassenge E. Novel organic nitrates are potent dilators of large coronary arteries with reduced development of tolerance during long-term infusion in dogs: role of the sulfhydryl moiety. J Cardiovasc Pharmacol. 1994;23:772–778.[Medline] [Order article via Infotrieve]
  37. Arnal JF, Rami J, Souchard JP, Tack I, Besombes JP. Role of the superoxide anion on biological activity of nitric oxide produced by the endothelium. Arch Physiol Biochem. 1996;104:D27–D28.
  38. Bassenge E, Fink B. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn Schmiedebergs Arch Pharmacol. 1996;353:363–367.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. Gori, J. S. Floras, and J. D. Parker
Effects of nitroglycerin treatment on baroreflex sensitivity andshort-term heart rate variability in humans
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2000 - 2005.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Gori and J. D. Parker
Nitrate Tolerance: A Unifying Hypothesis
Circulation, November 5, 2002; 106(19): 2510 - 2513.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. P. Patel, Y.-F. Li, and Y. Hirooka
Role of Nitric Oxide in Central Sympathetic Outflow
Experimental Biology and Medicine, October 1, 2001; 226(9): 814 - 824.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Zanzinger
Role of nitric oxide in the neural control of cardiovascular function
Cardiovasc Res, August 15, 1999; 43(3): 639 - 649.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zanzinger, J.
Right arrow Articles by Seller, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zanzinger, J.
Right arrow Articles by Seller, H.